Popular articles

Is Marburg virus manmade?

Is Marburg virus manmade?

Rousettus aegyptiacus, fruit bats of the Pteropodidae family, are considered to be natural hosts of Marburg virus. The Marburg virus is transmitted to people from fruit bats and spreads among humans through human-to-human transmission.

Who discovered the Marburg virus?

The Marburg virus was discovered in 1967 when some laboratory workers in Marburg and Frankfurt, Germany became ill with hemorrhagic fever. Some other medical personnel and family members of those affected also contracted the illness along with researchers in Belgrade, Serbia (formerly Yugoslavia).

How did the Marburg virus originate?

The first people infected had been exposed to Ugandan imported African green monkeys or their tissues while conducting research. One additional case was diagnosed retrospectively. The reservoir host of Marburg virus is the African fruit bat, Rousettus aegyptiacus.

What is the causative agent of Marburg virus?

Marburg virus (MARV) is the causative agent of Marburg virus disease (MVD) in humans, with a case fatality rate ranging from 23 to 90%, depending on the outbreak [1]. MARV is a member of the Filoviridae family, which consists of the genera Marburgvirus, Ebolavirus, Cuevavirus, Striavirus, and Thamnovirus [2, 3].

How contagious is Marburg?

Ebola and Marburg virus diseases are not airborne diseases and are generally considered not to be contagious before the onset of symptoms. Transmission requires direct contact with blood, secretions, organs, or other bodily fluids of dead or living infected people or animals.

Is Marburg virus curable?

There is no specific treatment for Marburg virus disease. Supportive hospital therapy should be utilized, which includes balancing the patient’s fluids and electrolytes, maintaining oxygen status and blood pressure, replacing lost blood and clotting factors, and treatment for any complicating infections.

How many people died from Marburg virus in the world?

From 1967–2012, 571 cases of Marburg virus disease including 470 deaths were reported.

Is Marburg the same as Ebola?

Ebola virus is part of the Filoviridae family, which also includes Marburg virus. Marburg virus disease was first recognized in 1967 and is characterized by the same symptoms and transmission routes as Ebola virus disease.

Is Marburg airborne?

Is Marburg or Ebola worse?

Marburg and Ebola viruses are filamentous filoviruses that are distinct from each other but that cause clinically similar diseases characterized by hemorrhagic fevers and capillary leakage. Ebola virus infection is slightly more virulent than Marburg virus infection.

Is Ebola worse than Marburg?

What kind of disease does the Marburg virus cause?

Marburg virus (MARV) causes Marburg virus disease in humans and nonhuman primates, a form of viral hemorrhagic fever. The virus is considered to be extremely dangerous. The World Health Organization (WHO) rates it as a Risk Group 4 Pathogen (requiring biosafety level 4-equivalent containment ).

When to use IgG capture ELISA for Marburg HF?

The IgG-capture ELISA is appropriate for testing persons later in the course of disease or after recovery. In deceased patients, immunohistochemistry, virus isolation, or PCR of blood or tissue specimens may be used to diagnose Marburg HF retrospectively. Treatment There is no specific treatment for Marburg hemorrhagic fever.

Who is at risk for Marburg hemorrhagic fever?

People who have close contact with African fruit bats, humans patients, or non-human primates infected with Marburg virus are at risk. Historically, the people at highest risk include family members and hospital staff who care for patients infected with Marburg virus and have not used proper barrier nursing techniques.

What kind of test is used for Marburg HF?

Antigen-capture enzyme-linked immunosorbent assay (ELISA) testing, virus isolation, polymerase chain reaction (PCR), and IgM- capture ELISA can be used to confirm a case of Marburg HF within a few days of symptom onset. The IgG-capture ELISA is appropriate for testing persons later in the course of disease or after recovery.